ARTICLE | Clinical News
Helicore lipid agent against Helicobacter pylori: The 20 patients in a Phase I trial have completed dosing
September 9, 1996 7:00 AM UTC
Novavax Inc. (NOX), Rockville, Md. Product: Helicore lipid agent against Helicobacter pylori Indication: Peptic ulcers Status: The 20 patients in a Phase I trial have completed dosing, and will be fol...